SCHEMBL208204

SCHEMBL208204

CN(C)CCNC(=O)c1ccc(-c2cc(Cl)c(CC3CCN(C4CCCCC4)C3=O)c(Cl)c2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4D Q08499 4/20 0.49
PDE7A Q13946 4/20 0.49
PDE1A P54750 3/20 0.49
PDE1B Q01064 3/20 0.49
PDE1C Q14123 3/20 0.49
PDE3A Q14432 2/20 0.49
MELK Q14680 1/20 0.42
HSD11B1 P28845 1/20 0.40
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
SETD7 Q8WTS6 1/20 0.39
CHRM4 P08173 1/20 0.39
THRB P10828 1/20 0.39
CCNT1 O60563 1/20 0.38
CDK4 P11802 1/20 0.38
CCND3 P30281 1/20 0.38
CDK9 P50750 1/20 0.38
PLK1 P53350 2/20 0.38
BRD4 O60885 1/20 0.38
BRDT Q58F21 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL210959 0.90 HSD11B1 (0.42) PDE4DPDE7APDE1APDE1BPDE1C
SCHEMBL209301 0.89 HSD11B1 (0.42) PDE4DPDE7APDE1APDE1BPDE1C
SCHEMBL210257 0.88 HSD11B1 (0.43) PDE7AHSD11B1MAPTTP53ALDH1A1
SCHEMBL15204226 0.88 HSD11B1 (0.39) PDE4DPDE7APDE1APDE1BPDE1C
SCHEMBL2720661 0.87 HRH3 (0.48) ALDH1A1HSD17B10
SCHEMBL209754 0.86 HSD11B1 (0.45) PDE7AHSD11B1MAPTALDH1A1KMT2A
SCHEMBL207210 0.86 PDE7A (0.41) PDE4DPDE7APDE1APDE1BPDE1C
SCHEMBL209956 0.86 HSD11B1 (0.45) PDE4DHSD11B1
SCHEMBL2722387 0.86 CNR2 (0.46) HSD11B1TP53ALDH1A1HPGDKMT2A
SCHEMBL211427 0.86 HSD11B1 (0.44) HSD11B1TP53ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US claimed
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed
WO-2007124337-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 PDE4D 1270/4885PDE7A 1372/4885PDE1A 771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.